Paul Allen has pledged $30 million to help house homeless families in Seattle, as the city grapples with an ongoing crisis and debates how to pay for it.
With an additional $5 million in capital from city coffers, the funding from... Read more »
Founding Director, Massachusetts Technology Transfer Center
Executive Partner, Sofinnova Ventures
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Chairman, CEO, & Founder, Alexandria Real Estate Equities
[Corrected 4/27/17, 11:57 p.m. See Below.] Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation... Read more »
This week, we’re looking forward to Saturday’s March for Science and back at Microsoft’s acquisition of Charles Simonyi’s Intentional Software; former Microsoft CEO Steve Ballmer’s new effort to inject facts into debate about government; potential changes to the high-skilled visa program... Read more »
Nobel Laureate David Baltimore. Microbiome AND supercomputer pioneer Larry Smarr. Intellectual Ventures’ Nathan Myhrvold. Nicole Glaros of Techstars.
These are just a few of the visionary speakers who will be headlining Xconomy’s sixth annual Napa Summit. And if you act... Read more »
Since opening its doors in Seattle in 2010, Techstars has polished up more than 100 startup companies through its 12-week accelerator program here.
Melissa Marotta pulled no punches to get her three-year-old son C.J., who has the genetic disease spinal muscular atrophy, access to nusinersen (Spinraza), the first approved drug for his condition. For months, she couldn’t schedule a treatment date at Columbia University... Read more »
Following a six-month trial of its digital mortgage platform, San Diego-based Approved has officially launched its Web-based software for home loan applications. In a recent statement, the 20-month-old startup also said it has raised $1 million in what co-founder and... Read more »
Mitch Gold, the controversial executive who oversaw the rise of now-defunct cancer immunotherapy pioneer Dendreon, is about to head back to Wall Street.
A group of Seattle-area angel investors is organizing a new tech-focused early stage venture capital fund.
Flying Fish Partners is described on its co-founders’ LinkedIn pages as an “early stage software technology investment firm investing in the Pacific Northwest.” Those co-founders... Read more »
Russian hackers reportedly used a barrage of “fake news” items to distract and confuse voters in the 2016 U.S. presidential election—crowding out genuine information that could better guide their decisions.
Data security analysts are already familiar with a similar tactic used... Read more »
In the nation’s capital, healthcare and life sciences were on center stage. Or stages, actually. On Capitol Hill, FDA commissioner nominee Scott Gottlieb, the drug industry’s favorite pick, told senators his extensive industry ties wouldn’t cloud his judgment or create conflicts.... Read more »
Seattle-area companies collected some $300 million in investment during the first quarter, with biotech and medical devices companies claiming four of the 10 largest deals.
The first-quarter investment total was up 33 percent from the first quarter of 2016, according to... Read more »
Qumulo’s founders, leadership team, and investors are all betting that the Seattle data storage technology provider can deliver a repeat of another local success story—and now they’ve got $30 million in fresh funding riding on it.
The five-year-old company brings together... Read more »
There were local antidotes this week for those who see global catastrophe in the Trump administration’s attempts to reverse course on federal policies combatting climate change.
On Thursday, scores of science, engineering, and business students from around the Pacific Northwest pitched... Read more »
Chairman of the Board, Oncothyreon
Founder, President, and Chief Scientific Officer, The Infectious Disease Research Institute
CEO and Founder, Intellectual Ventures
Dean, College of Engineering, University of Washington
Chief Revenue Officer, RealGames North America
Managing Director, GlobalSmartEnergy
Partner, Voyager Capital
Chairman, CEO, Acucela
President and CEO, VLST Corporation